BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8649608)

  • 1. Fosphenytoin use in children.
    Pellock JM
    Neurology; 1996 Jun; 46(6 Suppl 1):S14-6. PubMed ID: 8649608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of fosphenytoin: options for the management of seizures.
    Ramsay RE; DeToledo J
    Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular use of fosphenytoin: an overview.
    Uthman BM; Wilder BJ; Ramsay RE
    Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and pharmacokinetics of fosphenytoin.
    Browne TR; Kugler AR; Eldon MA
    Neurology; 1996 Jun; 46(6 Suppl 1):S3-7. PubMed ID: 8649612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of fosphenytoin sodium.
    Fierro LS; Savulich DH; Benezra DA
    Am J Health Syst Pharm; 1996 Nov; 53(22):2707-12. PubMed ID: 8931812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
    Popławska M; Borowicz KK; Czuczwar SJ
    Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosphenytoin in infants of extremely low birth weight.
    Kriel RL; Cifuentes RF
    Pediatr Neurol; 2001 Mar; 24(3):219-21. PubMed ID: 11301224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosphenytoin.
    Luer MS
    Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosphenytoin in infants.
    Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
    J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.
    DeToledo JC; Ramsay RE
    Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with fosphenytoin in children.
    Morton LD
    J Child Neurol; 1998 Oct; 13 Suppl 1():S19-22; discussion S30-2. PubMed ID: 9796748
    [No Abstract]   [Full Text] [Related]  

  • 16. Fosphenytoin: a novel phenytoin prodrug.
    Boucher BA
    Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery.
    Wilder BJ; Campbell K; Ramsay RE; Garnett WR; Pellock JM; Henkin SA; Kugler AR
    Arch Neurol; 1996 Aug; 53(8):764-8. PubMed ID: 8759983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advisers recommend improved labeling for phenytoin, fosphenytoin.
    Traynor K
    Am J Health Syst Pharm; 2010 Dec; 67(24):2086, 2089. PubMed ID: 21115998
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergency treatment of status epilepticus.
    Runge JW; Allen FH
    Neurology; 1996 Jun; 46(6 Suppl 1):S20-3. PubMed ID: 8649610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.